Stage at admission to BC. Stage IV pleural malignant mesothelioma

BC-July 28, 2006. PB, erlotinib, BVZ, cisplatin, pemetrexed

Regional radiology. PET December 5, 2006 and February 6, 2007

CR

VEGF and HER-2- elevated (blood)

4

Regional hospital February 22, 2006

Mesothelioma

Regional hospital CT February 18, 2006

Asbestosis in the lungs, plaques in the mesentery

Pemetrexed and cisplatin × 8 April 2006 to April 16, 2007

Regional radiology CT April 16, 2007

Recurrence

22.9

8.0

Stage at admission to BC. Stage IV pleural and peritoneal malignant mesothelioma

BC. May 22, 2007. PB, BVZ, erlotinib, sunitinib

Regional radiology CT July 13, 2007

PD

VEGF- elevated (blood)

5

Regional hospital March 5, 2008

Malignant mesothelioma

University hospital Chest X-ray March 31, 2008

Diffuse pleural thickening of right hemithorax

Pemetrexed and gemcitabine April 2008

Regional radiology PET/CT May 19, 2008

Recurrence

17.4

17.1

Stage at admission to BC. Stage IV pleural and peritoneal malignant mesothelioma

BC. May 16, 2008. PB, sorafenib, dasatinib

Regional radiology PET/CT September 4, 2008

SD

Negative (blood)

6

Regional hospital June 7, 2009

Malignant mesothelioma

Regional radiology CT April 17, 2009

Large ascites

Laparoscopy and omentectomy June 24, 2009. Laparotomy and partial excision of omentum. TAHBSO right diaphragm resection, appendectomy, cholecystectomy, colon and small bowel resection July 12, 2009, intraperitoneal doxorubicin and cisplatin

Regional radiology PET/CT July 19, 2011

Recurrence

63.0

+

37.8

+

Stage at admission to BC. Stage IV pleural and peritoneal malignant mesothelioma

BC. July 18, 2011. PB, erlotinib, sunitinib, sirolimus, vorinostat, trastuzumab, pazopanib, lapatinib

Regional radiology CT/PET December 14, 2011

SD

HER-2- elevated (blood). Tissue profiling- no targets